Visual and easy-to-use computer help for staying critical in structure-based design

webinar

Tue, 11 Aug 2015, 16:00 CEST (Berlin)

Dr. Marcus Gastreich, BioSolveIT GmbH, St. Augustin, Germany

Visual and easy-to-use computer help for staying critical in structure-based design

We tend to believe that PDB files are a message from God. — This recent statement from
blogger and Vertex scientist Dr. Derek Lowe ironically captures the danger of getting lost in false assumptions when working with crystal structure data.

We will use free tools and ours in this webinar to give you assistance in checking whether you are still on solid grounds with your work – or not. Be it crystal artifacts recorded, insecure assignments of N vs O vs C, wishful thinking in prior art – or just something unusual which might still be ok – There are very simple-to-use, visual indicators which we can use in our everyday work to alert us when things might get flakey.

Come and join us for minimum input and maximum output.

Current news

VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on
category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on